Press Releases
Hogan Lovells wins court battle with FTC over major Philadelphia healthcare merger
11 December 2020
PartnerWashington, D.C.
Email robert.leibenluft@hoganlovells.com
Phone +1 202 637 5789
Fax +1 202 637 5910
Practice groupGlobal Regulatory
Sources comment: "He is absolutely terrific and a spectacular antitrust lawyer." Chambers USA, 2018
Bob Leibenluft's antitrust practice is unusual in that it focuses on only one industry – health care and life sciences – yet it spans all industry sectors, including providers, payers, and drug and device manufacturers. He brings over 35 years of experience, including heading the FTC Health Care Division, to his representation of clients in counseling, investigations, transactions, and litigation matters.
Starting at the firm in 1981 as a health regulatory lawyer, Bob became a nationally recognized lawyer on Medicare issues. His deep understanding of the industry was a reason he was asked to lead the FTC Health Care Division in the mid-1990s, where he supervised drafting of the FTC/DOJ Health Policy Statements, which first addressed clinical integration, and led investigations of hospital mergers and physician networks.
On a pro bono basis, Bob has led a 10-year review of the D.C. government's response to HIV/AIDs, advised the government of Liberia on a new public health law, and provided antitrust advice to the CEO Roundtable on Cancer.
Chambers USA describes Bob as "renowned for his expertise in health care antitrust and is singled out by a source as someone who really knows how the system works" and who is hailed by peers as a "terrific health care antitrust lawyer."
Bob is an inaugural fellow and former vice president of the American Health Lawyers Association. He is a former Chair of the ABA Antitrust Section's Health and Pharmaceuticals Committee, Joint Conduct Committee, and State Enforcement Committee. Bob also served as Chair of the Board of Directors of HCI3, the parent of Prometheus Payment, and Bridges-to-Excellence. He teaches the course Antitrust in the Health Care Sector at George Washington School of Law, where he is an adjunct professor.
Antitrust (District of Columbia)
Chambers USA
Healthcare: Regulatory & Litigation (Nationwide)
Chambers USA
Healthcare (District of Columbia)
Chambers USA
Healthcare (District of Columbia)
Chambers USA
Healthcare: Advice to Health Insurers
Legal 500 US
Healthcare: Transactional (Nationwide)
Chambers USA
Antitrust Law
The Best Lawyers in America
Healthcare: Service Providers
Legal 500 US
Washington's Top Lawyers: Health Care
Washingtonian
Health Care, Antitrust Litigation
Washington, D.C. Super Lawyers
Top 25 for Health Care
Best of the Best USA
Outstanding Health Care Antitrust Lawyer
Nightingale's Health Care News
Guide to the Leading U.S. Health Care Lawyers
Education
J.D., University of California, Berkeley School of Law, Order of the Coif, 1980
B.A., Yale University, magna cum laude, 1973
Memberships
Former Chair, Board of Directors, Health Care Incentives Improvement, Inc. (parent of Prometheus Payment, Inc., and Bridges-to-Excellence)
Former Chair, Health Care and Pharmaceuticals Committee; Joint Conduct Committee; and State Enforcement Committee, Antitrust Section, American Bar Association
Inaugural Fellow, Past Vice President, and Member of the Board of Directors, American Health Lawyers Association
Bar admissions and qualifications
District of Columbia
Counseling numerous pharmaceutical companies regarding patent litigation settlements.
Counseling numerous drug and device manufacturers on pricing policies, including loyalty and volume discounts, bundling, and price discrimination.
Advising hospitals, physicians, health plans, and life science companies on merger clearance, HSR filings, and due diligence and integration planning.
Advising numerous physician networks and physician/hospital organizations regarding clinical integration.
Represented Advocate Health Partners in FTC investigation and litigation with a private health plan regarding its clinical integration program.
Technical advisor to grantees on RWJF Aligning Forces for Quality program re antitrust issues raised by employer/provider/health plan collaborations.
Defended several health plans in investigations by DOJ and state attorney generals regarding most-favored nation provisions.
Defended American Society for Reproductive Medicine in class action challenging ethical guideline on payments for egg donors; defeated damages class.
Press Releases
11 December 2020
Hogan Lovells Publications
07 May 2019
Published Works
01 February 2018
Webinar
20 June 2017
Hogan Lovells Publications
06 April 2017
Hogan Lovells Publications
24 June 2016